Once-Daily, Single-Tablet Regimens For the Treatment of HIV-1 Infection
- PMID: 25628507
- PMCID: PMC4296592
Once-Daily, Single-Tablet Regimens For the Treatment of HIV-1 Infection
Abstract
Once-daily, single-tablet regimens have become integral to the management of human immunodeficiency virus type 1 infection, partly because they may improve adherence due to a lower pill burden. This article reviews the single-tablet options.
References
-
- Hodder SL, Mounzer K, Dejesus E, et al. Patient-reported outcomes in virologically suppressed, HIV-1-infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF. AIDS Patient Care STDS. 2010;24(2):87–96. - PubMed
-
- Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30. - PubMed
-
- Ickovics JR, Cameron A, Zackin R, et al. Consequences and determinants of adherence to antiretroviral medication: results from adult AIDS clinical trials group protocol 370. Antivir Ther. 2002;7(3):185–193. - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases